140 related articles for article (PubMed ID: 7060038)
1. Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dog.
Pendyala L; Cowens JW; Creaven PJ
Cancer Treat Rep; 1982 Mar; 66(3):509-16. PubMed ID: 7060038
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer.
Pendyala L; Greco W; Cowens JW; Madajewicz S; Creaven PJ
Cancer Chemother Pharmacol; 1983; 11(1):23-8. PubMed ID: 6883623
[TBL] [Abstract][Full Text] [Related]
3. Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans.
Pendyala L; Cowens JW; Chheda GB; Dutta SP; Creaven PJ
Cancer Res; 1988 Jun; 48(12):3533-6. PubMed ID: 3370646
[TBL] [Abstract][Full Text] [Related]
4. Clinical development of iproplatin (CHIP).
Creaven PJ; Pendyala L; Madajewicz S
Drugs Exp Clin Res; 1986; 12(1-3):287-92. PubMed ID: 3732051
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP).
Creaven PJ; Madajewicz S; Pendyala L; Mittelman A; Pontes E; Spaulding M; Arbuck S; Solomon J
Cancer Treat Rep; 1983 Sep; 67(9):795-800. PubMed ID: 6883356
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
Cho YB; Kim KH; Kim DK
Drug Metab Dispos; 1995 Nov; 23(11):1280-5. PubMed ID: 8591731
[TBL] [Abstract][Full Text] [Related]
7. Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products.
Raynaud FI; Boxall FE; Goddard P; Barnard CF; Murrer BA; Kelland LR
Anticancer Res; 1996; 16(4A):1857-62. PubMed ID: 8712713
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of four platinum cytostatics in rats.
Láznícková A; Filipová M; Láznícek M; Drobník J; Svoboda D; Kvĕtina J
Neoplasma; 1987; 34(2):173-81. PubMed ID: 3600883
[TBL] [Abstract][Full Text] [Related]
9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic properties of antileukemic and trypanocidal compounds with amidino and imidazolinyl groups.
Gluth WP; Busch U
Arzneimittelforschung; 1984; 34(11):1542-51. PubMed ID: 6543129
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O) [(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]plat inum (II) in dogs.
Kim DK; Cho YB; Kim HT; Kim TS; Kim KH; Hong WS
Anticancer Res; 1996; 16(3A):1167-9. PubMed ID: 8702230
[TBL] [Abstract][Full Text] [Related]
13. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
[TBL] [Abstract][Full Text] [Related]
14. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
Litterst CL; LeRoy AF; Guarino AM
Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
[TBL] [Abstract][Full Text] [Related]
15. Reversible and irreversible interactions of a cisplatin analog bearing a 1,2-diphenylethylenediamine ligand with plasma and plasma proteins in vitro.
Bednarski PJ; Kratochwil NA; Otto AM
Drug Metab Dispos; 1994; 22(3):419-27. PubMed ID: 7520852
[TBL] [Abstract][Full Text] [Related]
16. Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease.
Thatcher N; Sharma H; Harrison R; Smith A; Zaki A; McAuliffe CA; Crowther D; Fox BW
Cancer Chemother Pharmacol; 1982; 9(1):13-6. PubMed ID: 6890414
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats.
Láznícková A; Láznícek M; Kvĕtina J; Drobník J
Cancer Chemother Pharmacol; 1986; 17(2):133-6. PubMed ID: 3521926
[TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of platinum following the administration of cis-(glycolato-O,O')[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in dogs.
Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
Anticancer Res; 1997; 17(5A):3681-3. PubMed ID: 9413223
[TBL] [Abstract][Full Text] [Related]
20. Rapid biotransformation of satraplatin by human red blood cells in vitro.
Carr JL; Tingle MD; McKeage MJ
Cancer Chemother Pharmacol; 2002 Jul; 50(1):9-15. PubMed ID: 12111106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
